Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta
| Status: | Archived |
|---|---|
| Conditions: | Smoking Cessation, Neurology, Psychiatric |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
Family Risk Analysis of Substance Use in ADHD Youth Treated With Concerta
The researchers will study 100 families over three years, each with a child (proband)
between the ages of 12-17, with the Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) diagnosis of ADHD. The researchers hypothesize smoking will be
familial and ADHD probands with a family history of tobacco use will be at increased risk
for early initiation and persistence of smoking, compared to ADHD probands with no family
history of tobacco use.
As Attention Deficit Hyperactivity Disorder (ADHD) is a documented risk factor for smoking
in adolescents, and as theoretical considerations suggest that ADHD and tobacco use may
share common underlying mechanisms, the proposed study looks to examine the association
between smoking and ADHD. Since both ADHD and smoking are known to be familial disorders,
one approach to examine the nature of the association between the two disorders is to
conduct a familial risk analysis comparing ADHD youth who smoke and ADHD youth who don't
smoke. Another approach is to conduct a genetic study, to identify candidate genes
associated with nicotine abuse and dependence in ADHD youth and relatives.
This study includes:
1. assessment of psychopathology and substance use/dependence,
2. assessment of the family environment, and
3. assessment of molecular genetics in 100 families with at least one child (proband)
between the ages of 12-17 with a DSM-IV diagnosis of ADHD.
We found this trial at
1
site
Click here to add this to my saved trials
